Genetic Testing in Pediatric Left Ventricular Noncompaction

Circulation: Cardiovascular Genetics

Volumn 10, Issue 6, 2017, Pages

  Miller, Erin M ^a   Hinton, Robert B ^a   Czosek, Richard ^a   Lorts, Angela ^a   Parrott, Ashley ^a   Shikany, Amy R ^a   Ittenbach, Richard F ^b   Ware, Stephanie M ^a,c  

^a CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^b Div of Biostatist and Epidemiology   (United States)

^c INDIANA UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

cardiomyopathies; genetic testing; infant; pediatrics; phenotype

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CARDIOMYOPATHY; CARDIOVASCULAR MALFORMATION; CHILD; CLINICAL FEATURE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE SEVERITY; ECHOCARDIOGRAPHY; FAMILIAL DISEASE; FAMILY HISTORY; FEMALE; GENETIC ASSOCIATION; GENETIC DISORDER; GENETIC SCREENING; GENETIC VARIABILITY; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; METABOLIC DISORDER; MYOCARDIAL DISEASE; PREDICTIVE VALUE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; VENTRICULAR NONCOMPACTION; YOUNG ADULT;

EID: 85038637801     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.117.001735     Document Type: Article

References (31)

1. Gupta V, Poss KD. Clonally dominant cardiomyocytes direct heart morphogenesis. Nature. 2012;484:479-484. doi: 10. 1038/nature11045.
2. Arbustini E, Weidemann F, Hall JL. Left ventricular noncompaction: a distinct cardiomyopathy or a trait shared by different cardiac diseases? J Am Coll Cardiol. 2014;64:1840-1850. doi: 10. 1016/j. jacc. 2014. 08. 030.
3. Stähli BE, Gebhard C, Biaggi P, Klaassen S, Valsangiacomo Buechel E, Attenhofer Jost CH, et al. Left ventricular non-compaction: prevalence in congenital heart disease. Int J Cardiol. 2013;167:2477-2481. doi: 10. 1016/j. ijcard. 2012. 05. 095.
4. Maron BJ, Towbin JA, Thiene G, Antzelevitch C, Corrado D, Arnett D, et al; American Heart Association; Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; Council on Epidemiology and Prevention. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807-1816. doi: 10. 1161/CIRCULATIONAHA. 106. 174287.
5. Biagini E, Ragni L, Ferlito M, Pasquale F, Lofiego C, Leone O, et al. Different types of cardiomyopathy associated with isolated ventricular noncompaction. Am J Cardiol. 2006;98:821-824. doi: 10. 1016/j. amjcard. 2006. 04. 021.
6. Andreini D, Pontone G, Bogaert J, Roghi A, Barison A, Schwitter J, et al. Long-term prognostic value of cardiac magnetic resonance in left ventricle noncompaction: a prospective multicenter study. J Am Coll Cardiol. 2016;68:2166-2181. doi: 10. 1016/j. jacc. 2016. 08. 053.
7. Probst S, Oechslin E, Schuler P, Greutmann M, Boyé P, Knirsch W, et al. Sarcomere gene mutations in isolated left ventricular noncompaction cardiomyopathy do not predict clinical phenotype. Circ Cardiovasc Genet. 2011;4:367-374. doi: 10. 1161/CIRCGENETICS. 110. 959270.
8. Klaassen S, Probst S, Oechslin E, Gerull B, Krings G, Schuler P, et al. Mutations in sarcomere protein genes in left ventricular noncompaction. Circulation. 2008;117:2893-2901. doi: 10. 1161/ CIRCULATIONAHA. 107. 746164.
9. Hoedemaekers YM, Caliskan K, Michels M, Frohn-Mulder I, van der Smagt JJ, Phefferkorn JE, et al. The importance of genetic counseling, DNA diagnostics, and cardiologic family screening in left ventricular noncompaction cardiomyopathy. Circ Cardiovasc Genet. 2010;3:232-239. doi: 10. 1161/CIRCGENETICS. 109. 903898.
10. Dellefave LM, Pytel P, Mewborn S, Mora B, Guris DL, Fedson S, et al. Sarcomere mutations in cardiomyopathy with left ventricular hypertrabeculation. Circ Cardiovasc Genet. 2009;2:442-449. doi: 10. 1161/ CIRCGENETICS. 109. 861955.
11. Shieh JT. Implications of genetic testing in noncompaction/hypertrabeculation. Am J Med Genet C Semin Med Genet. 2013;163C:206-211.
12. Kindel SJ, Miller EM, Gupta R, Cripe LH, Hinton RB, Spicer RL, et al. Pediatric cardiomyopathy: importance of genetic and metabolic evaluation. J Card Fail. 2012;18:396-403. doi: 10. 1016/j. cardfail. 2012. 01. 017.
13. Harris PA, Taylor R, Thielke R, Payne J, Gonzalez N, Conde JG. Research electronic data capture (REDCap)-a metadata-driven methodology and workflow process for providing translational research informatics support. J Biomed Inform. 2009;42:377-381. doi: 10. 1016/j. jbi. 2008. 08. 010.
14. Stöllberger C, Finsterer J. Left ventricular hypertrabeculation/noncompaction. J Am Soc Echocardiogr. 2004;17:91-100. doi: 10. 1016/ S0894-7317(03)00514-5.
15. Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666-671.
16. Hinton RB, McBride KL, Bleyl SB, Bowles NE, Border WL, Garg V, et al. Rationale for the cytogenomics of cardiovascular malformations consortium: a phenotype intensive registry based approach. J Cardiovasc Dev Dis. 2015;2:76-92.
17. Botto LD, Lin AE, Riehle-Colarusso T, Malik S, Correa A; National Birth Defects Prevention Study. Seeking causes: classifying and evaluating congenital heart defects in etiologic studies. Birth Defects Res A Clin Mol Teratol. 2007;79:714-727. doi: 10. 1002/bdra. 20403.
18. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med. 2015;17:405-424. doi: 10. 1038/gim. 2015. 30.
19. Grenier MA, Osganian SK, Cox GF, Towbin JA, Colan SD, Lurie PR, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J. 2000;139(2 pt 3):S86-S95.
20. Lek M, Karczewski KJ, Minikel EV, Samocha KE, Banks E, Fennell T, et al; Exome Aggregation Consortium. Analysis of protein-coding genetic variation in 60, 706 humans. Nature. 2016;536:285-291. doi: 10. 1038/ nature19057.
21. Campbell MJ, Czosek RJ, Hinton RB, Miller EM. Exon 3 deletion of ryanodine receptor causes left ventricular noncompaction, worsening catecholaminergic polymorphic ventricular tachycardia, and sudden cardiac arrest. Am J Med Genet A. 2015;167A:2197-2200. doi: 10. 1002/ ajmg. a. 37140.
22. Ackerman MJ, Priori SG, Willems S, Berul C, Brugada R, Calkins H, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Heart Rhythm. 2011;8:1308-1339. doi: 10. 1016/j. hrthm. 2011. 05. 020.
23. André F, Burger A, Losnitzer D, Buss SJ, Abdel-Aty H, Gianntisis E, et al. Reference values for left and right ventricular trabeculation and noncompacted myocardium. Int J Cardiol. 2015;185:240-247. doi: 10. 1016/j. ijcard. 2015. 03. 065.
24. Tizón-Marcos H, de la Paz Ricapito M, Pibarot P, Bertrand O, Bibeau K, Le Ven F, et al. Characteristics of trabeculated myocardium burden in young and apparently healthy adults. Am J Cardiol. 2014;114:1094-1099. doi: 10. 1016/j. amjcard. 2014. 07. 025.
25. Agarwal A, Khandheria BK, Paterick TE, Treiber SC, Bush M, Tajik AJ. Left ventricular noncompaction in patients with bicuspid aortic valve. J Am Soc Echocardiogr. 2013;26:1306-1313. doi: 10. 1016/j. echo. 2013. 08. 003.
26. Ramachandran P, Woo JG, Ryan TD, Bryant R, Heydarian HC, Jefferies JL, et al. The impact of concomitant left ventricular non-compaction with congenital heart disease on perioperative outcomes. Pediatr Cardiol. 2016;37:1307-1312. doi: 10. 1007/s00246-016-1435-2.
27. Jefferies JL, Wilkinson JD, Sleeper LA, Colan SD, Lu M, Pahl E, et al; Pediatric Cardiomyopathy Registry Investigators. Cardiomyopathy phenotypes and outcomes for children with left ventricular myocardial noncompaction: results from the Pediatric Cardiomyopathy Registry. J Card Fail. 2015;21:877-884. doi: 10. 1016/j. cardfail. 2015. 06. 381.
28. Walsh R, Thomson KL, Ware JS, Funke BH, Woodley J, McGuire KJ, et al. Reassessment of Mendelian gene pathogenicity using 7, 855 cardiomyopathy cases and 60, 706 reference samples. Genet Med. 2017;19:192-203. doi: 10. 1038/gim. 2016. 90.
29. Yang J, Bücker S, Jungblut B, Böttger T, Cinnamon Y, Tchorz J, et al. Inhibition of Notch2 by Numb/Numblike controls myocardial compaction in the heart. Cardiovasc Res. 2012;96:276-285. doi: 10. 1093/cvr/cvs250.
30. Chen H, Zhang W, Sun X, Yoshimoto M, Chen Z, Zhu W, et al. Fkbp1a controls ventricular myocardium trabeculation and compaction by regulating endocardial Notch1 activity. Development. 2013;140:1946-1957. doi: 10. 1242/dev. 089920.
31. Luxán G, Casanova JC, Martínez-Poveda B, Prados B, D'Amato G, Mac-Grogan D, et al. Mutations in the NOTCH pathway regulator MIB1 cause left ventricular noncompaction cardiomyopathy. Nat Med. 2013;19:193-201. doi: 10. 1038/nm. 3046.